223 related articles for article (PubMed ID: 26700560)
1. β-Cell Deficit in Obese Type 2 Diabetes, a Minor Role of β-Cell Dedifferentiation and Degranulation.
Butler AE; Dhawan S; Hoang J; Cory M; Zeng K; Fritsch H; Meier JJ; Rizza RA; Butler PC
J Clin Endocrinol Metab; 2016 Feb; 101(2):523-32. PubMed ID: 26700560
[TBL] [Abstract][Full Text] [Related]
2. Increased Hormone-Negative Endocrine Cells in the Pancreas in Type 1 Diabetes.
Md Moin AS; Dhawan S; Shieh C; Butler PC; Cory M; Butler AE
J Clin Endocrinol Metab; 2016 Sep; 101(9):3487-96. PubMed ID: 27300574
[TBL] [Abstract][Full Text] [Related]
3. Increased Frequency of Hormone Negative and Polyhormonal Endocrine Cells in Lean Individuals With Type 2 Diabetes.
Md Moin AS; Dhawan S; Cory M; Butler PC; Rizza RA; Butler AE
J Clin Endocrinol Metab; 2016 Oct; 101(10):3628-3636. PubMed ID: 27472443
[TBL] [Abstract][Full Text] [Related]
4. β-Cell Dedifferentiation in Patients With T2D With Adequate Glucose Control and Nondiabetic Chronic Pancreatitis.
Sun J; Ni Q; Xie J; Xu M; Zhang J; Kuang J; Wang Y; Ning G; Wang Q
J Clin Endocrinol Metab; 2019 Jan; 104(1):83-94. PubMed ID: 30085195
[TBL] [Abstract][Full Text] [Related]
5. {beta}-Cell mass dynamics and islet cell plasticity in human type 2 diabetes.
Hanley SC; Austin E; Assouline-Thomas B; Kapeluto J; Blaichman J; Moosavi M; Petropavlovskaia M; Rosenberg L
Endocrinology; 2010 Apr; 151(4):1462-72. PubMed ID: 20176718
[TBL] [Abstract][Full Text] [Related]
6. Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas.
Inaishi J; Saisho Y; Sato S; Kou K; Murakami R; Watanabe Y; Kitago M; Kitagawa Y; Yamada T; Itoh H
J Clin Endocrinol Metab; 2016 Jul; 101(7):2874-82. PubMed ID: 27070277
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.
Moin ASM; Butler AE
Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713
[TBL] [Abstract][Full Text] [Related]
8. Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes.
Amo-Shiinoki K; Tanabe K; Hoshii Y; Matsui H; Harano R; Fukuda T; Takeuchi T; Bouchi R; Takagi T; Hatanaka M; Takeda K; Okuya S; Nishimura W; Kudo A; Tanaka S; Tanabe M; Akashi T; Yamada T; Ogawa Y; Ikeda E; Nagano H; Tanizawa Y
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33427207
[TBL] [Abstract][Full Text] [Related]
9. Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes.
Cinti F; Bouchi R; Kim-Muller JY; Ohmura Y; Sandoval PR; Masini M; Marselli L; Suleiman M; Ratner LE; Marchetti P; Accili D
J Clin Endocrinol Metab; 2016 Mar; 101(3):1044-54. PubMed ID: 26713822
[TBL] [Abstract][Full Text] [Related]
10. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
[TBL] [Abstract][Full Text] [Related]
11. Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas.
Saisho Y
Rev Diabet Stud; 2016; 13(2-3):132-147. PubMed ID: 28012279
[TBL] [Abstract][Full Text] [Related]
12. Pancreas Fat and β Cell Mass in Humans With and Without Diabetes: An Analysis in the Japanese Population.
Murakami R; Saisho Y; Watanabe Y; Inaishi J; Tsuchiya T; Kou K; Sato S; Kitago M; Kitagawa Y; Yamada T; Itoh H
J Clin Endocrinol Metab; 2017 Sep; 102(9):3251-3260. PubMed ID: 28633420
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer.
Wang Y; Ni Q; Sun J; Xu M; Xie J; Zhang J; Fang Y; Ning G; Wang Q
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31781763
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes.
Grzesik WJ; Nadler JL; Machida Y; Nadler JL; Imai Y; Morris MA
J Clin Endocrinol Metab; 2015 Mar; 100(3):E387-95. PubMed ID: 25532042
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.
Talchai C; Xuan S; Lin HV; Sussel L; Accili D
Cell; 2012 Sep; 150(6):1223-34. PubMed ID: 22980982
[TBL] [Abstract][Full Text] [Related]
16. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review.
Inaishi J; Saisho Y
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33339276
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic beta-cell mass in European subjects with type 2 diabetes.
Rahier J; Guiot Y; Goebbels RM; Sempoux C; Henquin JC
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():32-42. PubMed ID: 18834431
[TBL] [Abstract][Full Text] [Related]
18. Impaired islet turnover in human donor pancreata with aging.
Reers C; Erbel S; Esposito I; Schmied B; Büchler MW; Nawroth PP; Ritzel RA
Eur J Endocrinol; 2009 Feb; 160(2):185-91. PubMed ID: 19004984
[TBL] [Abstract][Full Text] [Related]
19. Loss of β-cell identity and dedifferentiation, not an irreversible process?
Patel S; Remedi MS
Front Endocrinol (Lausanne); 2024; 15():1414447. PubMed ID: 38915897
[TBL] [Abstract][Full Text] [Related]
20. Islet microangiopathy and augmented β-cell loss in Japanese non-obese type 2 diabetes patients who died of acute myocardial infarction.
Takahashi K; Mizukami H; Osonoi S; Takeuchi Y; Kudoh K; Sasaki T; Daimon M; Yagihashi S
J Diabetes Investig; 2021 Dec; 12(12):2149-2161. PubMed ID: 34032392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
